WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

2 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Maude Laboratory In the Press

AddtoAny
Share:
1 - 4 of 4

T-cell Therapy Pioneered at CHOP Shows Persistent Benefits in Young Leukemia Patients

Published on Feb 1, 2018 in Press Releases
CHOP Oncologists Update Analysis in Pivotal Global Trial of CAR T-Cell Treatment for Relapsed or Refractory ALL

Pediatric Immunotherapy: What’s Next for CAR-T Therapy

Published on Oct 20, 2017
On Aug. 30, 2017, the U.S. Food and Drug Administration approved the use of chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of relapsed or refractory pediatric and young adult patients with B-cell acute lymphoblastic leukemia (ALL).

FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of Philadelphia

Published on Aug 29, 2017 in Press Releases
Pioneering CAR T-cell Studies Led to First-ever Cancer Cell and Gene Therapy Approval

FDA Committee Recommends Approving First Cell Therapy to Successfully Treat Cancer

Published on Jul 12, 2017
The experimental, personalized cell therapy that amps up the patient's own immune system has passed a critical milestone.
1 - 4 of 4